NGL FINE-CHEM LIMITED

NGLFINE.NS
Exchange NSI, Currency in INR
Loading price...

Overview

Previous Close--
Open--
Ask--
Bid--
Day's Range -
52 Week Range -
PE Ratio(TTM)--
Market Cap--
Volume₹NaN
Avg. Volume₹NaN
Face Value₹NaN
Dividend Yield--

Profit/Loss

PARTICULARS
No results to display

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - General
HQ Location: Mumbai, India
Website: https://www.nglfinechem.com
CEO, MD, Chief Ethics Counsellor & Executive Director: Mr. Rahul Jayant Nachane ACA, B. Com, DBF, MMS
Employees: 498
About Company:
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.